Peptonic Medical AB Composition for Treating Climacteric Disorders EP3634376A1
Summary
The European Patent Office published patent application EP3634376A1 filed by Peptonic Medical AB for a composition intended for treating or preventing climacteric disorders. The application names three inventors: Dan Markusson, Johan Inborr, and Anders Carlsson. Publication occurred on April 15, 2026, establishing the priority date and making the application publicly available under IPC classifications covering pharmaceutical formulations (A61K 9/00, 9/06, 47/38, 31/717) and therapeutic applications (A61P 15/12, 15/02). The designation covers 31 European Patent Convention contracting states including Germany, France, the United Kingdom, Italy, Spain, Sweden, and the Netherlands. Peptonic Medical AB's patent remains under prosecution and would require separate grant proceedings and national phase entry to achieve full protection in each designated state.
About this source
GovPing monitors EPO Patent Bulletin - Pharma (A61K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 72 changes logged to date.
What changed
The EPO published patent application EP3634376A1 for a composition to treat or prevent climacteric disorders, naming Peptonic Medical AB as applicant and Dan Markusson, Johan Inborr, and Anders Carlsson as inventors. The application covers pharmaceutical formulations under IPC classes A61K 9/00, 9/06, 47/38, and 31/717, with therapeutic classifications A61P 15/12 and 15/02.
Affected parties include Peptonic Medical AB, which has secured priority rights for this intellectual property in 31 designated EPC contracting states. Competitors developing similar women's health or hormone-related therapies should review the published claims for potential freedom-to-operate concerns or licensing opportunities. The patent application is now publicly accessible and will undergo examination before any grant of enforceable rights.
Archived snapshot
Apr 25, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
COMPOSITION FOR TREATING OR PREVENTING CLIMACTERIC DISORDERS
Publication EP3634376A1 Kind: A1 Apr 15, 2026
Applicants
Peptonic Medical AB
Inventors
MARKUSSON, Dan, INBORR, Johan, CARLSSON, Anders
IPC Classifications
A61K 9/00 20060101AFI20181207BHEP A61K 9/06 20060101ALI20181207BHEP A61K 47/38 20060101ALI20181207BHEP A61K 31/717 20060101ALI20181207BHEP A61P 15/12 20060101ALI20181207BHEP A61P 15/02 20060101ALI20181207BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.